Anacetrapib, a cholesteryl ester transfer protein inhibitor

Author： Hooper Amanda J   Burnett John R  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.1, 2012-01, pp. : 103-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cholesteryl ester transfer protein inhibitors

By Shinkai H.  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 5, 2001-05 ,pp. : 739-745

Informa Healthcare

Access to resources Recommend Favorite

Dalcetrapib, a cholesteryl ester transfer protein modulator

By Hooper Amanda J   Burnett John R  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1427-1432

Informa Healthcare

Access to resources Recommend Favorite

Cholesteryl Ester Transfer Protein (CETP) Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 5, 2009-04 ,pp. : 419-427

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of cholesteryl ester transfer protein – a new approach to coronary artery disease

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 99-106

Informa Healthcare

Access to resources Recommend Favorite

The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 19, Iss. 17, 2013-05 ,pp. : 3143-3149

Bentham Science Publishers

Access to resources Recommend Favorite